• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织因子通过诱导趋化因子(C-C 基元)配体 2 的表达来调节微血管的形成和稳定。

Tissue factor regulates microvessel formation and stabilization by induction of chemokine (C-C motif) ligand 2 expression.

机构信息

Cardiovascular Research Center, Hospital de Sant Pau, IIB-Sant Pau, Barcelona, Spain.

出版信息

Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2607-15. doi: 10.1161/ATVBAHA.111.233536.

DOI:10.1161/ATVBAHA.111.233536
PMID:21868706
Abstract

OBJECTIVE

Tissue factor (TF) triggers arterial thrombosis. TF is also able to initiate cellular signaling mechanisms leading to angiogenesis. Because high cardiovascular risk atherosclerotic plaques show significant angiogenesis, our objective was to investigate whether TF is able to trigger and stabilize atherosclerotic plaque neovessel formation.

METHODS AND RESULTS

In this study, we showed, by real-time confocal microscopy in 3-dimensional basement membrane cocultures, that TF in human microvascular endothelial cells (HMEC-1) and in human vascular smooth muscle cells (HVSMCs) plays an important role in the formation of capillary-like networks. TF silencing in endothelial cells and smooth muscle cells inhibits the formation of tube-like structures with stable phenotype. Using an in vivo model, we observed that TF inhibition in either HMEC-1 or HVSMCs reduced their shared ability to form new capillaries. The phenotypic changes induced by TF silencing were linked to reduced chemokine (C-C motif) ligand 2 (CCL2) expression in endothelial cells. Wound healing and chemotactic assays demonstrated that TF-induced release of CCL2 stimulated HVSMC migration to HMEC-1.

CONCLUSION

Endogenous TF regulates CCL2 production in endothelial cells. Secreted CCL2 mediates the angiogenic effect of TF by recruiting smooth muscle cells toward endothelial cells and facilitates the maturation of newly formed microvessels.

摘要

目的

组织因子 (TF) 可引发动脉血栓形成。TF 还能够启动细胞信号转导机制,导致血管生成。由于心血管风险高的动脉粥样硬化斑块显示出明显的血管生成,我们的目的是研究 TF 是否能够引发和稳定动脉粥样硬化斑块新生血管形成。

方法和结果

在这项研究中,我们通过在 3 维基底膜共培养物中的实时共聚焦显微镜显示,TF 在人微血管内皮细胞 (HMEC-1) 和人血管平滑肌细胞 (HVSMCs) 中在形成毛细血管样网络中发挥重要作用。内皮细胞和血管平滑肌细胞中的 TF 沉默抑制了具有稳定表型的管状结构的形成。使用体内模型,我们观察到 TF 抑制在 HMEC-1 或 HVSMCs 中均减少了它们形成新毛细血管的共同能力。TF 沉默引起的表型变化与内皮细胞中趋化因子 (C-C 基序) 配体 2 (CCL2) 的表达减少有关。伤口愈合和趋化性测定表明,TF 诱导的 CCL2 释放刺激 HVSMC 向 HMEC-1 的迁移。

结论

内源性 TF 调节内皮细胞中 CCL2 的产生。分泌的 CCL2 通过招募平滑肌细胞向内皮细胞并促进新形成的微血管成熟,介导 TF 的血管生成作用。

相似文献

1
Tissue factor regulates microvessel formation and stabilization by induction of chemokine (C-C motif) ligand 2 expression.组织因子通过诱导趋化因子(C-C 基元)配体 2 的表达来调节微血管的形成和稳定。
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2607-15. doi: 10.1161/ATVBAHA.111.233536.
2
Angiogenic microvascular endothelial cells release microparticles rich in tissue factor that promotes postischemic collateral vessel formation.血管生成的微血管内皮细胞释放富含组织因子的微粒,促进缺血后侧支血管的形成。
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):348-57. doi: 10.1161/ATVBAHA.114.303927. Epub 2014 Nov 25.
3
Protein disulphide-isomerase A2 regulated intracellular tissue factor mobilisation in migrating human vascular smooth muscle cells.蛋白二硫键异构酶 A2 调控迁移的人血管平滑肌细胞内组织因子的动员。
Thromb Haemost. 2015 Apr;113(4):891-902. doi: 10.1160/TH14-09-0776. Epub 2015 Jan 29.
4
Ets-1 transcription is required in tissue factor driven microvessel formation and stabilization.Ets-1 转录是组织因子驱动的微血管形成和稳定所必需的。
Angiogenesis. 2012 Dec;15(4):657-69. doi: 10.1007/s10456-012-9293-x. Epub 2012 Aug 7.
5
mCRP triggers angiogenesis by inducing F3 transcription and TF signalling in microvascular endothelial cells.修饰性C反应蛋白通过诱导微血管内皮细胞中的F3转录和组织因子信号传导来触发血管生成。
Thromb Haemost. 2017 Jan 26;117(2):357-370. doi: 10.1160/TH16-07-0524. Epub 2016 Nov 3.
6
PAR2-SMAD3 in microvascular endothelial cells is indispensable for vascular stability via tissue factor signaling.微血管内皮细胞中的PAR2-SMAD3通过组织因子信号传导对血管稳定性不可或缺。
J Mol Cell Biol. 2016 Jun;8(3):255-70. doi: 10.1093/jmcb/mjv065. Epub 2015 Dec 9.
7
Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro.在体外血管生成过程中,大鼠主动脉平滑肌细胞会转变为周细胞。
Lab Invest. 1995 Nov;73(5):658-66.
8
Endogenous NO blockade enhances tissue factor expression via increased Ca2+ influx through MCP-1 in endothelial cells by monocyte adhesion.内源性一氧化氮阻断通过单核细胞黏附增加内皮细胞中钙离子内流,经由单核细胞趋化蛋白-1增强组织因子表达。
Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):2005-11. doi: 10.1161/01.ATV.0000178171.61754.cd. Epub 2005 Jul 14.
9
Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design.雷帕霉素而非FK-506可增加内皮组织因子表达:对药物洗脱支架设计的启示。
Circulation. 2005 Sep 27;112(13):2002-11. doi: 10.1161/CIRCULATIONAHA.105.569129. Epub 2005 Sep 19.
10
Ets2 determines the inflammatory state of endothelial cells in advanced atherosclerotic lesions.Ets2 决定了晚期动脉粥样硬化病变中内皮细胞的炎症状态。
Circ Res. 2011 Aug 5;109(4):382-95. doi: 10.1161/CIRCRESAHA.111.243444. Epub 2011 Jun 23.

引用本文的文献

1
bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile.碱性成纤维细胞生长因子通过调节脂肪来源干细胞的微小RNA谱,挽救2型糖尿病患者脂肪来源干细胞的功能障碍特性。
Diabetologia. 2025 Sep 4. doi: 10.1007/s00125-025-06533-0.
2
Crosstalk of human coronary perivascular adipose-derived stem cells with vascular cells: role of tissue factor.人冠状动脉血管周脂肪来源干细胞与血管细胞的串扰:组织因子的作用。
Basic Res Cardiol. 2024 Apr;119(2):291-307. doi: 10.1007/s00395-024-01037-1. Epub 2024 Mar 2.
3
C-C Motif Chemokine Ligand 2 Enhances Macrophage Chemotaxis, Osteogenesis, and Angiogenesis during the Inflammatory Phase of Bone Regeneration.
C-C 基序趋化因子配体 2 增强骨再生炎症期的巨噬细胞趋化、成骨和血管生成。
Biomolecules. 2023 Nov 18;13(11):1665. doi: 10.3390/biom13111665.
4
Chemokines, molecular drivers of thromboinflammation and immunothrombosis.趋化因子:血栓炎症和免疫血栓形成的分子驱动因素。
Front Immunol. 2023 Oct 26;14:1276353. doi: 10.3389/fimmu.2023.1276353. eCollection 2023.
5
Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging.用于癌症治疗的单克隆抗体的治疗靶点:现状与新进展
Biomedicines. 2023 Jul 24;11(7):2086. doi: 10.3390/biomedicines11072086.
6
CD142 promotes trophoblast cell migration by inhibiting BCL2-related autophagic degradation of IL-8.CD142通过抑制白细胞介素-8(IL-8)与BCL2相关的自噬降解来促进滋养层细胞迁移。
In Vitro Cell Dev Biol Anim. 2023 Feb;59(2):131-141. doi: 10.1007/s11626-023-00751-9. Epub 2023 Feb 27.
7
Application of stem cell-derived exosomes in ischemic diseases: opportunity and limitations.干细胞衍生的外泌体在缺血性疾病中的应用:机遇与局限。
J Transl Med. 2021 May 8;19(1):196. doi: 10.1186/s12967-021-02863-w.
8
Clinical significance of microvessels detected by in vivo optical coherence tomography within human atherosclerotic coronary arterial intima: a study with multimodality intravascular imagings.体内光学相干断层扫描检测人动脉粥样硬化性冠状动脉内膜内微血管的临床意义:多模态血管内成像研究。
Heart Vessels. 2021 Jun;36(6):756-765. doi: 10.1007/s00380-020-01756-0. Epub 2021 Jan 6.
9
Stem cells from human cardiac adipose tissue depots show different gene expression and functional capacities.人心房脂肪组织来源的干细胞表现出不同的基因表达和功能能力。
Stem Cell Res Ther. 2019 Nov 29;10(1):361. doi: 10.1186/s13287-019-1460-1.
10
Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases.使用干细胞衍生的细胞外囊泡进行治疗性血管生成:一种治疗缺血性疾病的新兴方法。
Stem Cell Res Ther. 2019 Jun 3;10(1):158. doi: 10.1186/s13287-019-1276-z.